Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-29

Clinical Trial Update: HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Cervical Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial update notes that a Phase 1/2 study evaluating HepaSphere Interventional Therapy using digital subtraction angiography for cervical cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HepaSphere Interventional Therapy

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Cervical Carcinoma | Phase 1, Phase 2 | Status: COMPLETED